<DOC>
	<DOC>NCT01823393</DOC>
	<brief_summary>To assess if the non use of heparin sodium during balloon aortic valvuloplasty reduces serious complications due to the procedure, by decreasing the rate of vascular and hemorrhagic complications without increasing the rate of ischeamic events.</brief_summary>
	<brief_title>Balloon Aortic Valvuloplasty Performed Without Heparin to Decrease Vascular and Bleeding Complications of the Procedure</brief_title>
	<detailed_description />
	<mesh_term>Aortic Valve Stenosis</mesh_term>
	<mesh_term>Calcium heparin</mesh_term>
	<mesh_term>Heparin</mesh_term>
	<criteria>be over 18 carry a tight and symptomatic aortic stenosis have an indication for a ballon aortic valvuloplasty Subject have signed his written informed consent Have an absence of femoral surgical approach have a criticial hemodynamic state, considered as outdrove for the treatment have a severe aortic failure allergia to heparin contraindication to heparin or/and local anaesthetic be treted by low molecular weight heparin in less than 12 hoursbefore the intervention or by standard heparin in less than 4 hours before the valvulopasty have a tight but not symptomatic aortic stenosis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>balloon aortic valvuloplasty indication</keyword>
	<keyword>heparin</keyword>
	<keyword>hemorrhagic</keyword>
	<keyword>ischemic</keyword>
</DOC>